Astria Therapeutics Patents – Insights & Stats (Updated 2024)

Astria Therapeutics has a total of 285 patents globally, out of which 102 have been granted. Of these 285 patents, more than 18% patents are active. The United States of America is where Astria Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Astria Therapeutics.

Astria Therapeutics was founded in 2008. Astria Therapeutics is a biopharmaceutical company focused on developing treatments for rare allergic and immunological diseases. Their main program, STAR-0215, is a monoclonal antibody being developed to treat hereditary angioedema. They also have another product, STAR-0310, which is a monoclonal antibody in development for treating atopic dermatitis, a skin condition causing itching and loss of skin barrier function.

Do read about some of the most popular patents of Astria Therapeutics which have been covered by us in this article and also you can find Astria Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Astria Therapeutics patent portfolio.

How many patents does Astria Therapeutics have?

Astria Therapeutics has a total of 285 patents globally. These patents belong to 38 unique patent families. Out of 285 patents, 53 patents are active.

How Many Patents did Astria Therapeutics File Every Year?

Astria Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAstria Therapeutics Applications FiledAstria Therapeutics Patents Granted
202062
201923
20183113
2017420
2016620
20151918
20142513
2013325
2012456
2011452
201035

How many Astria Therapeutics patents are Alive/Dead?

Worldwide Patents

Astria Therapeutics Patent Portfolio

How Many Patents did Astria Therapeutics File in Different Countries?

Astria Therapeutics Worldwide Patent Filing

Countries in which Astria Therapeutics Filed Patents

CountryPatent
United States of America64
Europe (EPO)18
Japan12
Israel11
Australia10
China10
Canada10
New Zealand8
Mexico8
Brazil8
Korea (South)8
Singapore6
Philippines5
Spain5
Germany5
Malaysia5
Hong Kong (S.A.R.)5
Chile4
Austria4
South Africa4
India4
Taiwan3
Norway3
Argentina3
Denmark3
Costa Rica3
Ecuador3
Viet Nam3
Colombia3
Nicaragua3
Indonesia2
Guatemala2
Croatia1
Lithuania1
Hungary1
El Salvador1
Honduras1
Poland1
Malta1
Portugal1
Estonia1
Cyprus1
Slovenia1

Where are Research Centers of Astria Therapeutics Patents Located?

R&D Centres of Astria Therapeutics

10 Best Astria Therapeutics Patents

WO2011085211A1 is the most popular patent in the Astria Therapeutics portfolio. It has received 165 citations so far from companies like Boehringer Ingelheim International Gmbh, Cellix Bio Pvt Ltd, Alkermes Pharma Ireland Ltd.

Below is the list of 10 most cited patents of Astria Therapeutics:

Publication NumberCitation Count
WO2011085211A1165
WO2011028689A174
WO2011106688A171
WO2012115695A170
US20110172240A167
US20130190327A155
WO2016086136A150
WO2013166176A144
WO2010006085A140
WO2016086103A140

What are Astria Therapeutics key innovation segments?

What Technologies are Covered by Astria Therapeutics?

The chart below distributes patents filed by Astria Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Astria Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Astria Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Astria Therapeutics?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.